— Know what they know.
Not Investment Advice

NEPH NASDAQ

Nephros, Inc.
1W: -12.8% 1M: -12.6% 3M: +3.9% YTD: -22.3% 1Y: -20.1% 3Y: +136.5% 5Y: -57.7%
$3.67
+0.00 (+0.00%)
 
Weekly Expected Move ±7.2%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 38 · $39.8M mcap · 9M float · 0.208% daily turnover · Short 30% of daily vol

Balance Sheet Trends

Total Assets
$14M +21.7% ▲
5Y CAGR: -5.9%
Total Liabilities
$3M +31.0% ▲
5Y CAGR: +3.2%
Shareholders Equity
$10M +18.8% ▲
5Y CAGR: -4.0%
Cash & Investments
$5M +43.6% ▲
5Y CAGR: -8.1%
Total Debt
$1M -24.7% ▼
5Y CAGR: -13.3%
Net Debt
-$4M -84.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$7M$4M$4M$4M$5M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$7M$4M$4M$4M$5M
Net Receivables$2M$1M$1M$2M$2M
Inventory$4M$3M$2M$3M$3M
Other Current Assets$351K$0$132K$142K$177K
Total Current Assets$14M$8M$8M$8M$11M
Property, Plant & Equip.$686K$1M$2M$2M$1M
Goodwill & Intangibles$2M$2M$1M$1M$1M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$2M$54K$86K$50K$214K
Total Non-Current Assets$4M$3M$3M$3M$2M
Total Assets$18M$11M$12M$11M$14M
— Liabilities —
Accounts Payable$1M$740K$873K$649K$914K
Short-Term Debt$248K$71K$0$0$391K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$51K$0$0$0$1M
Total Current Liabilities$2M$1M$2M$2M$3M
Long-Term Debt$99K$1K$0$0$0
Other Non-Current Liab.$72K$0$0$0$0
Total Non-Current Liabilities$511K$706K$1M$1M$672K
Total Liabilities$3M$2M$4M$3M$3M
— Equity —
Common Stock$10K$10K$10K$11K$11K
Retained Earnings-$136M-$143M-$144M-$144M-$143M
Accumulated OCI$64K$0$0$0$0
Total Stockholders Equity$12M$6M$8M$9M$10M
Total Liabilities & Equity$18M$11M$12M$11M$14M
— Key Metrics —
Total Debt$1M$1M$2M$1M$1M
Net Debt-$6M-$3M-$2M-$2M-$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms